General MedicationsORALStandard
VENCLEXTA
VENETOCLAX
Standard Dose
10MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview VENCLEXTA is listed in Drugs@FDA under application 208573 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient VENETOCLAX Form and strength TABLET;ORAL - 10MG Sponsor ABBVIE Submission history Latest submission status date: 2026-02-19 00:00:00.
Structured Monograph
Clinical summary
Approval overview VENCLEXTA is listed in Drugs@FDA under application 208573 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient VENETOCLAX Form and strength TABLET;ORAL - 10MG Sponsor ABBVIE Submission history Latest submission status date: 2026-02-19 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.